Jiangsu Nanfang Medical Stock Forum

Investors' belief that the company's revenue growth might underperform the broader industry is causing a low P/S ratio. The company's recent medium-term revenue decline is contributing to its low P/S, and the share price is unlikely to experience significant movement if these trends persist.